ChemicalBook > Product Catalog >API >Hormones and the Endocrine System >Sex Hormone Drugs >Goserelin

Goserelin

Goserelin Structure
CAS No.
65807-02-5
Chemical Name:
Goserelin
Synonyms
Zoladex;Goserlin;Goserelin validation mixture CRS;Pbtbo;ici118630;Goserelin;Geserelin;Gosereline;decapeptidei;Goserelin-d7
CBNumber:
CB4281027
Molecular Formula:
C59H84N18O14
Molecular Weight:
1269.41
MOL File:
65807-02-5.mol
Modify Date:
2023/11/24 16:35:22

Goserelin Properties

Density 1.50±0.1 g/cm3(Predicted)
storage temp. −20°C
solubility H2O: 20 mg/mL, clear, colorless
form white powder
pka 9.82±0.15(Predicted)
InChIKey BLCLNMBMMGCOAS-URPVMXJPSA-N

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07,GHS08
Signal word  Danger
Hazard statements  H334-H332-H317
Precautionary statements  P261-P272-P280-P302+P352-P333+P313-P321-P363-P501-P261-P285-P304+P341-P342+P311-P501-P261-P271-P304+P340-P312
Safety Statements  22-24/25
WGK Germany  3
HS Code  3504009000

Goserelin Chemical Properties,Uses,Production

Description

Goserelin is an analog of luteinizing hormone-releasing hormone (LHRH) useful in the treatment of malignancies responsive to hormonal manipulation. Administered parenterally in a biodegradable depot, goserelin is reportedly as effective as orchidectomy and oophorectomy in patients with advanced prostate carcinoma and pre-menopausal breast cancer.

Chemical Properties

White or almost white powder.

Uses

Labeled Goserelin, intended for use as an internal standard for the quantification of Goserelin by GC- or LC-mass spectrometry.

Side effects

Hot flashes (flushing), dizziness, headache, increased sweating, decreased sexual interest/ability, trouble sleeping, nausea, change in breast size, vaginal dryness, or hair loss may occur. Pain, bruising, bleeding, redness, or swelling at the injection site may also occur.
This medication may rarely make your blood sugar rise, which can cause or worsen diabetes.
Serious side effects including: symptoms of a heart attack (such as chest/jaw/left arm pain, shortness of breath, unusual sweating), signs of a stroke (such as weakness on one side of the body, trouble speaking, sudden vision changes, confusion), fast/irregular heartbeat, severe dizziness, fainting.
In men using this medication for prostate cancer, a rare but very serious urinary blockage problem or spinal cord problem (compression) can occur, especially during the first month of treatment.

Drug interactions

Goserelin may be given on its own or is often combined with another hormone therapy such as tamoxifen or drugs known as aromatase inhibitors (anastrozole, exemestane and letrozole).
The risk or severity of QTc prolongation can be increased when Goserelin is combined with Clozapine. The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Cocaine.

Global( 151)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Ralington Pharma +91-7948911722 +91-9687771722 Gujarat, India 1350 58 Inquiry
Manus Aktteva +91 (79) 6512-3395 New Delhi, India 581 34 Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
SynZeal Research Pvt Ltd +1 226-802-2078 Gujarat, India 6522 58 Inquiry
Pharma Affiliates 172-5066494 Haryana, India 6761 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
Hardik Onco Care 08047642620 Ahmedabad, India 7 58 Inquiry
Nantong Guangyuan Chemicl Co,Ltd +undefined17712220823 China 616 58 Inquiry
Shenzhen Nexconn Pharmatechs Ltd +86-755-89396905 +86-15013857715 China 10311 58 Inquiry
Shaanxi Pioneer Biotech Co., Ltd . +8613259417953 China 3000 58 Inquiry
GOSERELIN ACETATE SALT (D-SER(TBU)6,AZAGLY10)-GONADOTROPIN-RELEASING HORMONE ACETATE SALT (D-SER(TBU)6,AZAGLY10)-LHRH ACETATE SALT (D-SER(TBU)6,AZAGLY10)-LUTEINIZING HORMONE-RELEASING FACTOR ACETATE SALT (D-SER(TBU)6,AZAGLY10)-LUTEINIZING HORMONE-RELEASING HORMONE ACETATE SALT PYR-HIS-TRP-SER-TYR-D-SER(TBU)-LEU-ARG-PRO-AZAGLY-NH2 ACETATE SALT 2-(aminocarbonyl)hydrazide decapeptidei d-ser(t-bu)(sup6)aza-gly(sup10)-gnrh ici118630 luteinizinghormone-releasingfactor(pig),6-(o-1,1-dimethylethyl)-d-serene)-1 1-9-Luteinizing hormone-releasing factor (swine), 6-[O-(1,1-dimethylethyl)-D-serine]-, 2-(aminocarbonyl)hydrazide Luteinizing hormone-releasing factor (pig), 6-[O-(1,1-dimethylethyl)-D-serine]-10-deglycinamide-, 2-(aminocarbonyl)hydrazide Goserelin 6-[O-(1,1-Dimethylethyl)-D-serine]-10-deglycirmmideluteinizing hormone-releasing factor(pig)2-(aminocarbonyl)hydrazide 5-Oxo-L-Pro-L-His-L-Trp-L-Ser-L-Tyr-O-(1,1-dimethylethyl)-D-Ser-L-Leu-L-Arg-L-Pro-ureido-NH2 Einecs 263-657-4 Pbtbo Phenol, 4,4'-(2,2-dioxido-3H-1,2-benzoxathiol-3-ylidene)bis(2,6-dibromo-3-methyl-, sodium salt (1:1) Sodium alpha-(3,5-dibromo-2-methyl-4-oxo-2,5-cyclohexadienylidene)-alpha-(3,5-dibromo-4-hydroxyphenyl)toluenesulphonate Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azagly-Gly-NH2 (D-Ser(tBu)6,Azagly10)-LHRH (free base) Goserelin (free base) GOSERELIN ACETATE PH. EUR. Human Goserelin Goserelin-d7 Geserelin Goserelin, Gosereline, Goserelinum, Goserelina Goserelin for NMR identification CRS Goserelin CRS Goserelin/Zoladex/Decapeptide I Goserelin USP/EP/BP Goserelin Deuterated Acetate DISCONTINUED Goserelin D10Q: What is Goserelin D10 Q: What is the CAS Number of Goserelin D10 Q: What is the storage condition of Goserelin D10 Q: What are the applications of Goserelin D10 Goserelin-d7Q: What is Goserelin-d7 Q: What is the CAS Number of Goserelin-d7 Goserelin Acetate(net) Zoladex Goserlin Goserelin validation mixture CRS Gosereline endo-5a-glycine-gonadorelin Goserelin-d7 Tritrifluoroacetate 65807-02-5 145781-95-6 C59H84N18O14 Pepetides peptides hormones